CAS: 2097938-64-0
| Marchio | Dati del prodotto | Purezza | Fascia di prezzo | Consegna prevista |
|---|---|---|---|---|
 | N-[4-(3-Aminopiperidin-1-yl)-5-bromo-1H-indol-3-yl]cyclopropanecarboxamide REF: 3D-XID93864CAS: 2097938-64-0 | Min. 95% | 525,00 €~4.453,00 € | Ven 20 Giu 25 |
 | CHK1 inhibitor REF: TM-T10793CAS: 2097938-64-0 | 98% | 1.374,00 €~2.660,00 € | Gio 07 Ago 25 |
![N-[4-(3-Aminopiperidin-1-yl)-5-bromo-1H-indol-3-yl]cyclopropanecarboxamide](https://static.cymitquimica.com/products/3D/thumb/XID93864.jpg)
N-[4-(3-Aminopiperidin-1-yl)-5-bromo-1H-indol-3-yl]cyclopropanecarboxamide
CAS:2097938-64-0
Please enquire for more information about N-[4-(3-Aminopiperidin-1-yl)-5-bromo-1H-indol-3-yl]cyclopropanecarboxamide including the price, delivery time and more detailed …
Formula:
C17H21BrN4O
Purezza:
Min. 95%
Peso molecolare:
377.3 g/mol
Ref: 3D-XID93864
| 1mg | 525,00 € | ||
| 5mg | 1.524,00 € | ||
| 10mg | 2.375,00 € | ||
| 25mg | 4.453,00 € |
Consegna stimata in Stati Uniti, il Venerdì 20 Giugno 2025
CHK1 inhibitor
CAS:2097938-64-0
CHK1 inhibitor (GDC-0575 analog) is a CHK1 inhibitor.
Formula:
C17H21BrN4O
Purezza:
98%
Colore e forma:
Solid
Peso molecolare:
377.28
Ref: TM-T10793
| 25mg | 1.586,00 € | ||
| 50mg | 2.072,00 € | ||
| 100mg | 2.660,00 € |
Consegna stimata in Stati Uniti, il Giovedì 07 Agosto 2025
